Highly Potent 2-Oxoester Inhibitors of Cytosolic Phospholipase A2 (GIVA cPLA2)-Reference-Cited by-同舟云学术

Highly Potent 2-Oxoester Inhibitors of Cytosolic Phospholipase A2 (GIVA cPLA2)

Published:2018-08-09 Issue:8 Volume:3 Page:8843-8853
ISSN:2470-1343
Container-title:ACS Omega
language:en
Short-container-title:ACS Omega

Author:

Psarra Anastasia¹,Kokotou Maroula G.¹,Galiatsatou Gerasimia¹,Mouchlis Varnavas D.²^ORCID,Dennis Edward A.²,Kokotos George¹^ORCID

Affiliation:

1. Department of Chemistry, National and Kapodistrian University of Athens, Panepistimiopolis, Athens 15771, Greece

2. Department of Pharmacology and Department of Chemistry and Biochemistry, School of Medicine, University of California San Diego, La Jolla, California 92093-0601, United States

Funder

General Secretariat for Research and Technology

European Regional Development Fund

Division of Graduate Education

National Institute of General Medical Sciences

Publisher

American Chemical Society (ACS)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.acs.org/doi/pdf/10.1021/acsomega.8b01214

Reference23 articles.

1. Phospholipase A2 Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention

2. Review of four major distinct types of human phospholipase A2

3. Eicosanoid storm in infection and inflammation

4. Cytosolic phospholipase A2: physiological function and role in disease

5. Inhibitors of phospholipase A2 and their therapeutic potential: an update on patents (2012-2016)

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. N,N-Disubstituted 4-Sulfamoylbenzoic Acid Derivatives as Inhibitors of Cytosolic Phospholipase A_2α: Synthesis, Aqueous Solubility, and Activity in a Vesicle and a Whole Blood Assay;Medicinal Chemistry;2024-12

2. Green synthesis, density functional theory (DFT), molecular docking, molecular dynamics simulation and biological activity of 1,2,3,4-tetrahydropyrimidine-5-carbonitrile derivatives as PLA2 and proteinase K inhibitors;Arabian Journal of Chemistry;2024-06

3. Phospholipase Family Enzymes in Lung Cancer: Looking for Novel Therapeutic Approaches;Cancers;2023-06-19

4. The importance of phospholipases A2 in Alzheimer's disease mechanisms, pathology, and potential therapies;Phospholipases in Physiology and Pathology;2023

5. The design and discovery of phospholipase A2 inhibitors for the treatment of inflammatory diseases;Expert Opinion on Drug Discovery;2021-07-15